InvestorsHub Logo
Followers 93
Posts 21466
Boards Moderated 0
Alias Born 06/07/2011

Re: Garden Rose post# 2025

Thursday, 05/20/2021 3:47:11 PM

Thursday, May 20, 2021 3:47:11 PM

Post# of 23069
India Health Ministry as of today still promoting hydroxycholoroquine and ivermectin for early treatment

Under the category of "low certainty of evidence". In another words the gov flocked up on its handling of Covid. So to cover up their incompetence they are invoking the "placebo effect".

(guess those pharma labs aren't producing and none are being set up "fast")



Here is why India has a vaccine shortage. Call it incompetency on the part of both the Indian gov, and the vaccine manufacturer SII.

Highlights include:

AZN sent "seed virus" to SII in May 2020. SII starts small production in Jun. CEO Poonawalla apparently is more interested in keeping his company's risk low. If the Indian regulators didn't approve the AZN vaccine, he didn't want to take a huge loss, with a large inventory of vaccine.

In October we have:

The official wondered too, though, why Poonawalla kept asking for money, given SII had $800 million—”more than enough”—to plow into its operations



SII wants mega money up front.

Then comes Jan, the magic moment:

Indian regulators approve SII’s AstraZeneca vaccine, named Covishield, for use. (They also approve Covaxin, another vaccine developed by an Indian firm called Bharat Biotech.) Shortly afterwards, India places its first order—an absurdly small one, for just 11 million doses of Covishield and 5.5 million of Covaxin



Then at the end of Jan:

Late in January, a fire breaks out on the fifth floor of a building under construction on the SII campus. Poonawalla says that the accident will not hurt the production of Covishield, and that it will only affect a planned expansion of vaccines for other diseases.



It's unclear how many doses Poonawalla&SII made.

In Feb SII claims it can make 60M a month. And the Indian gov orders another 10M for their 1.36B population. SII starts to export vaccine, 35M from Jan-Apr.

April the 2nd wave in India is picking up, and finally the Indian gov places a real order - for 100M doses. SII in response...

Poonawalla asks the government for a grant of $403 million, to expand his capacity to 100 million doses a month and meet India’s new orders.

On the one hand, Poonawalla now claims that the fire on his campus in January has set back his production targets of Covishield, contradicting his earlier statement. But through one of his other companies, he has also just bought a 60% stake in a financial services firm for around $500 million—a move unrelated to the pandemic, but indicative of his financial health. Weeks later, he will announce an investment of $333 million in a new research facility—in the UK.



SII using a fire as an excuse to bilk the Indian gov.

Finally the Indian gov says no more exporting vaccines.

If you want an example of Pharma greed on a global scale, and a Gov that had no idea what they were doing, then India is the example.

Contrast with the US. Pfizer took the risk of expanding manufacturing before drug approval, as did Moderna. tRUMP somehow managed to order 100M doses from each on condition of approval. Then came approval in Dec-Jan, with both Pfizer, and Moderna releasing sufficient vaccine for the first vaccinations of Medical personnel. Biden when he took office immediately ordered another 100M doses from each. To cover all adults. From the manufacturers position, they knew how much they would have to produce, had planned for it, and ramped up very quickly over a couple of months. Quite different from India, where SII was trying to screw the Indian gov, who in turn was playing footsie initially with 10M orders.

So yeah, what you see is what you get. But India's problem had nothing to do with your suggestion it's soooooo difficult to manufacture vaccine.



The Jewel of the Mind is Colored with the Hue of what it Imagines

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.